First Time Loading...

agilon health inc
NYSE:AGL

Watchlist Manager
agilon health inc Logo
agilon health inc
NYSE:AGL
Watchlist
Price: 5.09 USD -0.78%
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

AGL Price Targets Summary
agilon health inc

Wall Street analysts forecast AGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGL is 8.19 USD with a low forecast of 5.05 USD and a high forecast of 14.7 USD.

AGL Lowest Forecast
Wall Street Target
5.05 USD
1% Downside
AGL Average Forecast
Wall Street Target
8.19 USD
61% Upside
AGL Highest Forecast
Wall Street Target
14.7 USD
189% Upside
Lowest
Price Target
5.05 USD
1% Downside
Average
Price Target
8.19 USD
61% Upside
Highest
Price Target
14.7 USD
189% Upside
agilon health inc Competitors:
Price Targets
QC7
Q & M Dental Group (Singapore) Ltd
54% Upside
E
EHAB
Enhabit Inc
13% Upside
O
OPTIMAX
Optimax Holdings Bhd
30% Upside
600682
Nanjing Xinjiekou Department Store Co Ltd
47% Upside
QC7
Q & M Dental Group (Singapore) Ltd
54% Upside
E
EHAB
Enhabit Inc
13% Upside
O
OPTIMAX
Optimax Holdings Bhd
30% Upside
600682
Nanjing Xinjiekou Department Store Co Ltd
47% Upside
AGTI
Agiliti Inc
1% Upside
600763
Topchoice Medical Co Inc
60% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
7% Downside
G
2273
Gushengtang Holdings Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
agilon health inc

For the last 3 years the compound annual growth rate for agilon health inc's revenue is 52%. The projected CAGR for the next 3 years is 32%.

52%
Past Growth
32%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
agilon health inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
agilon health inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
What are analyst estimates?

See Also

Summary
AGL intrinsic value, competitors valuation, and company profile.
DCF Valuation
AGL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AGL stock valuation using valuation multiples.
Wall Street Estimates
AGL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AGL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGL's stock price target?
Price Target
8.19 USD

According to Wall Street analysts, the average 1-year price target for AGL is 8.19 USD with a low forecast of 5.05 USD and a high forecast of 14.7 USD.

What is agilon health inc's Revenue forecast?
Projected CAGR
32%

For the last 3 years the compound annual growth rate for agilon health inc's revenue is 52%. The projected CAGR for the next 3 years is 32%.

ALPHA SPREAD
Join more than 131,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.